A strong IP regime is critical for Malaysia


PHARMACEUTICAL companies have been accused of making slight modifications to their drugs to extend a patent life span.

This has resulted in calls for the government to not recognise process methods for patenting, and allowing only molecular patents.

Subscribe now for a chance to win your dream holiday!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Health , Business , Phama , patents

   

Next In Nation

Biden drops re-election bid, does not endorse Harris as candidate
Firemen clear up chemical spill on remote Tawau road
Foreigner detained for pickpocketing at KLIA Terminal 1
Man nabbed after wife reports him for possessing gun after argument
Fire breaks out at Pulau Burung landfill
Poh Yu Tian, 15, is youngest Malaysian to get International Master chess title
Paralympians deserve same rewards as Olympians if they bring home gold, says Adam Adli
Four wardens, two students escape unhurt in Kapit dorm fire
Cyberbullying: Govt to take action against social media platforms, says Fahmi
RM1mil allocated to rebuild bridges in Sabah damaged during floods

Others Also Read